Minimally Invasive Surgery and rhTNK-tPA for Intracerebral Hemorrhage Evacuation

NCT06668441 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Intracranial Hemorrhages
Cerebrovascular Disorders
Cerebral Hemorrhage
Hemorrhage

Interventions

DRUG: Minimally invasive surgery plus low-dose rhTNK-tPA group
DRUG: Minimally invasive surgery plus medium dose rhTNK-tPA group
DRUG: Minimally invasive surgery plus high dose rhTNK-tPA group

Sponsor

Beijing Tiantan Hospital